Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging
about
Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteinsCofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot studySpontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free statusENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluidsHIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subsetDiminished frequency of hepatitis C virus specific interferon secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patientsMechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infectionCD154 and type-1 cytokine response: from hyper IgM syndrome to human immunodeficiency virus infectionHIV and Tuberculosis: a Deadly Human SyndemicHIV Envelope gp120 Alters T Cell Receptor Mobilization in the Immunological Synapse of Uninfected CD4 T Cells and Augments T Cell ActivationImmunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions.Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signalsHIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activationFully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper responseImmune and hematopoietic parameters in HIV-1-infected chimpanzees during clinical progression toward AIDS.Chemokine coreceptor signaling in HIV-1 infection and pathogenesis.Decreased ability of HIV-1 tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells.Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy.Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1.Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus diseaseTransforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection.Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.Immunological memory and acquired immunodeficiency syndrome pathogenesis.Allergic diseases in subjects under 18 years living with HIVHigh-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteersInfluence of prior exposure to zidovudine on stavudine phosphorylation in vivo and ex vivoCytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infectionIn vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.HIV immunotherapeutic vaccines.Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease.Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina.Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.Cellular immune responses to HIV.
P2860
Q24517026-1654F971-9325-490E-8BDF-7AEAEB3E7CFCQ24645950-119438FC-82AE-4072-BE20-F60CA59286EFQ24672737-7B678CD2-32A9-4F7A-83DE-0476138E5328Q24682788-276767C1-19A0-4223-8ED5-CB9F6EF7A1FCQ24792182-A4940FAD-68D8-40C5-A8FE-AA2709F5CA8EQ27477581-F4554D1A-44B8-4287-A154-C1D32DDDB2B3Q28081838-055070E9-98D2-4D7D-A5FD-C9022406A650Q28203801-F24946DF-F8BB-4420-8386-E7E3DCBF8701Q30052157-BFEF73F0-4B7C-4C49-BE90-494CDD6A342DQ30828739-17AC880F-E4D7-422D-8EDD-48AD44C3309BQ33321334-38F99F2F-F61F-4793-80CD-897FE0531DC7Q33359540-F3070F70-F765-465A-B461-6802CA4D4D9FQ33359564-B3E465A8-572F-45EA-81ED-AAF7E1E87520Q33381644-71A0ED7A-55D4-42CA-A1F1-5845EC9E3859Q33500138-BF2DAE2B-9590-4F4D-BE0C-27517FC63A4CQ33521304-B6A538D7-DB3B-457D-ADA4-39F439F3CA5DQ33730729-F1D3C74A-4CD5-41B7-804B-07F0C4849606Q33780497-969C95BF-3CD2-4D51-B55C-62E8F15AA460Q33806165-2E110D65-B92C-4C2C-B519-0C965F336B0BQ33814659-9A8F9049-248A-476F-9475-850AD88AE3C3Q33814773-2CBA1E2C-552F-4677-9656-068EFC304EC8Q33817369-258ADA91-31D0-4C3B-9A81-9693D03B8E69Q33836036-6AE66B0D-4464-408D-B773-29BAEFF53BA7Q33847162-F6F76FBE-84D7-46E1-AF4C-E42CB4DB2E40Q33864034-9C586866-F330-4FF9-8B1B-C7A655F18498Q33892180-7BF2DAA9-0B2A-4569-A993-5BBCD90DDCF8Q33905225-0B7E30FA-9DEC-4BAA-8701-77131309279CQ33926804-A6B22EAD-F7D0-4768-AF51-FF265F0764A0Q33950164-214D13CE-BDB7-48D6-9803-4BD7269377F3Q33980114-9B0FC415-A1FC-478A-A616-2800395C8B8CQ33981459-2B2D6B8F-200B-4C2D-8A0E-C08997661234Q33997410-71CE293D-F60C-49DC-A3A6-36EA335F492EQ34050143-C3B97498-5132-41E3-8924-B0341E3AC220Q34121204-5724949B-71DE-4FF3-BD1B-34CB98399D76Q34126859-A40D5834-9917-4411-A112-BDF79FC592CDQ34130886-63667C81-B5CB-4184-9DCA-8779F4A51D30Q34169863-2990317C-6E54-4249-AEE4-34A7E1815926Q34194927-D36C8CDA-F39A-4864-9716-7F2B6AB10F5CQ34197974-D2F77F8D-7B13-4F95-A27F-1A551B7D07B2Q34223069-8799C40F-8589-42A7-B755-FF18309D688C
P2860
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Detection of three distinct pa ...... l numbers and clinical staging
@ast
Detection of three distinct pa ...... l numbers and clinical staging
@en
Detection of three distinct pa ...... l numbers and clinical staging
@nl
type
label
Detection of three distinct pa ...... l numbers and clinical staging
@ast
Detection of three distinct pa ...... l numbers and clinical staging
@en
Detection of three distinct pa ...... l numbers and clinical staging
@nl
prefLabel
Detection of three distinct pa ...... l numbers and clinical staging
@ast
Detection of three distinct pa ...... l numbers and clinical staging
@en
Detection of three distinct pa ...... l numbers and clinical staging
@nl
P2093
P2860
P356
P1476
Detection of three distinct pa ...... l numbers and clinical staging
@en
P2093
P2860
P304
P356
10.1172/JCI114376
P407
P577
1989-12-01T00:00:00Z